GlobeNews Wire

Oculis Appoints Katie Kazem as Chief Legal Officer

Ms. Kazem brings extensive and global expertise in corporate governance and securities law, drawing on a distinguished track record as…

4 months ago

FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference

Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator advancing toward IND-enabling studies for TRD HEIDELBERG, Germany,…

4 months ago

Inventiva reports preliminary 2025 fiscal year financial results

Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits2 as of December 31, 2025Revenues of €4.5…

4 months ago

TTEC Sets New Standard for AI-Driven Frontline Performance with TTEC Perform and TTEC RealSkill

AUSTIN, Texas, Feb. 16, 2026 (GLOBE NEWSWIRE) -- TTEC Holdings, Inc. (NASDAQ: TTEC), a leading global CX (customer experience) technology…

4 months ago

UTI GROUP : Nominations et acquisition du groupe MALTEM par ROBINSON TECHNOLOGIES

A la suite de l’Assemblée Générale Extraordinaire qui s’est tenue le lundi 16 février 2026, Monsieur Romain Aumard et Monsieur…

4 months ago

Transactions in connection with share buyback programme

Company announcement No. 13/2026                                                  16 February 2026 Transactions in connection with share buyback programmeOn 3 February 2026, Netcompany Group…

4 months ago

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntingtons Disease and Establishes Clinical Advisory Board

HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated target in…

4 months ago

Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470

Press Release Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470U.S. NDA submission on track for…

4 months ago

Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season

Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that…

4 months ago

Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City

Jennings-Brown will drive AI and technology strategy and lead the development of capabilities enabling discovery of therapeutics targeting fundamental aging…

4 months ago